A group of consumers who purchased Nexium, a heartburn medication, in Massachusetts since March 2001 filed a class-action lawsuit against AstraZeneca.  They claimed that the pharmaceutical company deceptively marketed the medication as superior to its other heartburn drugs so that consumers would buy the more expensive Nexium.  In October 2012, AstraZeneca agreed to settle the lawsuit but the terms of the settlement have not yet been announced. (Commonwealth Care Alliance v. AstraZeneca Pharmaceuticals L.P., Case No. 05-0269)


The Latest


TINA.org Reports Meal Kit Giant HelloFresh to FTC

Press Release

TINA.org Reports Meal Kit Giant HelloFresh to FTC

MADISON, CONN. June 22, 2022 While millions of Americans struggle with rising food prices and empty store shelves, meal kit retailer HelloFresh advertises “delicious meals delivered to your door,” enticing consumers…

Show More